The nuclear hormone receptor liver X receptor (LXR) is induced by insulin and is a key regulator of lipid metabolism. It promotes lipogenesis and cholesterol efflux, but suppresses endoplasmic reticulum stress and inflammation. The goal of these studies was to dissect the effects of insulin on LXR action. We used antisense oligonucleotides to knock down Lxr␣ in mice with hepatocytespecific deletion of the insulin receptor and their controls. We found, surprisingly, that knock-out of the insulin receptor and knockdown of Lxr␣ produced equivalent, non-additive effects on the lipogenic genes. Thus, insulin was unable to induce the lipogenic genes in the absence of Lxr␣, and LXR␣ was unable to induce the lipogenic genes in the absence of insulin. However, insulin was not required for LXR␣ to modulate the phospholipid profile, or to suppress genes in the ER stress or inflammation pathways. These data show that insulin is required specifically for the lipogenic effects of LXR␣ and that manipulation of the insulin signaling pathway could dissociate the beneficial effects of LXR on cholesterol efflux, inflammation, and ER stress from the negative effects on lipogenesis.
Obesity and diabetes have risen to epidemic proportions in our society with more than one in three individuals meeting criteria for diabetes or the pre-diabetic state of metabolic syndrome (1) . Although these disorders have traditionally been considered disorders of glucose metabolism, it has become increasingly clear that they are equally well described as disorders of lipid metabolism (2) . In particular, obesity and Type 2 diabetes are associated with increased hepatic lipogenesis (3) , which promotes the development of non-alcoholic fatty liver disease as well as hypertriglyceridemia and cardiovascular dis-ease. Therapies to prevent non-alcoholic fatty liver disease and cardiovascular disease in diabetic patients are limited, and the development of novel therapies has been hampered by our poor understanding of the molecular pathogenesis of these disorders.
How lipogenesis can be increased in the insulin-resistant liver is perplexing (4) . Insulin, which coordinates the transition from fasting to feeding, acts on the normal liver to suppress glucose production and stimulate de novo lipogenesis. Consequently, the fed liver, in response to insulin, synthesizes lipids rather than glucose. In the insulin-resistant states of obesity and Type 2 diabetes, insulin loses its ability to suppress glucose production. However, lipogenesis is still increased.
A key transcriptional regulator of lipogenesis is the nuclear hormone receptor liver X receptor (LXR, 3 also known as NR1H3). It is thought that insulin induces LXR by stimulating the production of its oxysterol ligands (5) . LXR binds directly to the promoters of the lipogenic enzymes fatty acid synthase (Fasn) and stearoyl CoA desaturase 1 (Scd1), and activates their transcription (6) . Perhaps even more importantly, LXR activates transcription of two other lipogenic transcription factors, sterol regulatory element-binding protein-1c (SREBP-1c) (7) and carbohydrate response element-binding protein (ChREBP) (8) . SREBP-1c is capable of activating the entire complement of genes necessary for the synthesis of monounsaturated fatty acids (9, 10) and is an important mediator of the lipogenic response to insulin (11) . ChREBP promotes lipogenic gene expression in response to glucose (12) .
In addition to being a powerful regulator of lipogenesis (13), LXR plays a key role in promoting cholesterol efflux and reverse cholesterol transport (14) . Thus, the accumulation of excess cholesterol also drives the production of oxysterols, thereby activating LXR and inducing the genes necessary to remove cholesterol from the cell. LXR also suppresses inflammation (15) and prevents endoplasmic reticulum (ER) stress (16) . More recently, LXR has been shown to play a role in regulating the phospholipid profile (16 -18) . These effects have been ascribed to the ability of LXR to activate transcription of the enzyme lysophosphatidylcholine acyltransferase 3 (LPCAT3) (19) , which preferentially produces phosphatidylcholine (PC) with unsaturated fatty acids, particularly arachidonic acid (20:4) and linoleic acid (18:2), at the sn-2 position. Thus, activation of LPCAT3 increases the unsaturated fatty acid content of PC, which would be expected to increase membrane fluidity and reduce ER stress (19) .
The overall goal of these studies was to determine how insulin and LXR interact in the regulation of gene expression. We used antisense oligonucleotides (ASO) to knock down LXR in liver insulin receptor knockout (LIRKO) mice. We found that the effects of Lxra knockdown on the lipogenic genes, but not the ER stress and inflammatory genes, were lost in the absence of hepatic insulin signaling.
Experimental Procedures
Animals, Diets, and Treatments-Generation and genotyping of LIRKO (Cre ϩ/Ϫ , IR lox/lox ) mice and their littermate Flox controls (Cre Ϫ/Ϫ , IR lox/lox ) have been described previously (20, 21) . These studies were performed in LIRKO mice maintained on a mixed genetic background, including 129/Sv, C57BL/6, FVB, and DBA, and inbred for more than 30 generations; however, mice backcrossed more than eight generations onto the C57Bl/6 background showed similar changes in hepatic gene expression in response to liver-specific knock-out of the insulin receptor and Lxr␣ knockdown (data not shown). Mice were housed with a 12-h light cycle (7:00 a.m. to 7:00 p.m.) and fed a standard rodent chow. Control second generation antisense oligonucleotides (ISIS-141923, CCTTCCCTGAAGGTTCCTCC) and second generation antisense oligonucleotides targeting LXR␣ (ISIS-232386, ATGCAAGTGTTGCCTCCCTG) were diluted in normal saline. Mice were given a 50 mg/kg intraperitoneal injection of ASO each week for five doses. Four days before sacrifice, the mice were switched from a normal chow diet to a 60% fructose diet (TD.00202, Harlan Teklad diets). Mice were then sacrificed at 2 p.m. in the non-fasted state, 1 day after the final dose of antisense oligonucleotides. At this time, plasma and liver were collected for analysis. All animal experiments were performed with the approval of the Institutional Animal Care and Use Committee at Boston Children's Hospital.
Gene Expression Analysis-RNA was isolated, and 2 g were used for reverse transcription (Applied Biosystems, Foster City, CA). The resultant cDNA was diluted 10-fold and used for realtime PCR analysis with SYBR green reagents (Fermentas). Results were normalized to Tbp expression. Primer sequences used for the study were published previously (22, 23) or listed as follows: Lxr␣, 5Ј-TGTTGACTTTGCCAAACAGC; 5Ј-GCAA-AGTCTTCCCGGTTGTA; Lxr␤, 5Ј-CAGAGAACTTGTGG-GGGAAG; 5Ј-AGGGCAACAGAGTCGGAGAC; Rxr, 5Ј-GGC-AGCTGCACTCTCCTATC; 5Ј-GGGTTCATGGGTGAATT-GAG; Chrebp-␤ 5Ј-TCTGCAGATCGCGTGGAG; 5Ј-CTTG-TCCCGGCATAGCAAC; Abca1, 5Ј-CATCCTCTCCCAGA-GCAAAA; 5Ј-CCACATCCACAACTGTCTGG; Abcg1, 5Ј-TCCGGATTCTTTGTCAGCTT; 5Ј-GATGGCCTCTGACTT-CTGGA; Abcg5, 5Ј-TGCCCATTCCTTTAAAAATCC; 5Ј-GATGAACTGGACCCCTTGG; Abcg8, 5Ј-GGGGCTGATGC-AGATTCA; 5Ј-GTAGCTGATGCCGATGACAA; Pltp, 5Ј-GGCCGTCTCAGTGCTAAGTT; 5Ј-CGAAGTTGATACCCT-CAGGAA; Cyp7a1, 5Ј-GTCGGATATTCAAGGATGCA; 5Ј-AGCAACTAAACAACCTGCCAGTAC; Lpcat3, 5Ј-GGGAC-AAATGGCTTAAGGTG; 5Ј-CTTTTCTTGGCACCATT-GCT; Atf3, 5Ј-ATGAGAGGAAAAGGAGGCGG; 5Ј-TTCAG-CTCCTCAATCTGGGC; Mcp1, 5Ј-AGGTCCCTGTCATGC-TTCTG; 5Ј-GCTGCTGGTGATCCTCTTGT; Tnf␣, 5Ј-TCA-AAATTCGAGTGACAAGCCT; 5Ј-TGTCTTTGAGATCCA-TGCCG; Xbp1s, 5Ј-GGTCTGCTGAGTCCGCAGCAGG; 5Ј-AGGCTTGGTGTATACATGG; Hsl, 5Ј-AAGACCTTGCCG-CCTGTG; 5Ј-TCTTCTACCACTTTGAGCGTC; Atgl, 5Ј-AAA-GAGCAGACGGGTAGCAT; 5Ј-GCACAGAGGGCAGAGACT.
Western Blotting-Liver lysates were prepared by homogenizing 50 mg of liver in 50 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.3% SDS, 10 mM NaF, 10 mM Na 3 VO 4 , 10 mM sodium ␤-glycerophosphate, and protease inhibitors (Roche Applied Science), centrifuging at 13,000 ϫ g for 10 min at 4°C, and collecting the supernatant as described previously (24) . 100 g of lysate (for Western blotting phospho-PERK and PERK), 50 g of lysate (for Western blotting all other hepatic proteins), or 0.4 l of plasma were loaded onto an SDS-PAGE gel and transferred to a polyvinylidene fluoride membrane (Immobilon). After 1 h in Hepatic Lipid Assays-Hepatic lipids were extracted using the method of Folch (25) . Colorimetric reagents were used for measuring total cholesterol and triglycerides (Thermo Scientific). Phospholipid analysis was performed as described previously (18) .
Plasma Lipid Assays-Plasma was obtained using EDTAtreated syringes. Colorimetric assays were used for measuring plasma cholesterol, triglycerides (Thermo Scientific), and free fatty acids (Wako Chemicals). PLTP activity (Sigma-Aldrich) and lipoprotein lipase activity (Cell Biolabs) were measured Fig. 1 . A and D, hepatic lipogenic (A) and lipolytic gene expression (D) was measured by real-time PCR (n ϭ 5). B, protein levels of ACC, FASN, and SCD1 were assessed by Western blotting in liver lysates. C, triglycerides were measured in the liver (n ϭ 5) and plasma (n ϭ 9 -13) taken at the time of sacrifice in the non-fasted state. E, free fatty acids (n ϭ 3-5) and lipoprotein lipase (LPL) enzymatic activity (n ϭ 3-6) were measured in non-fasted plasma collected at sacrifice. Data are presented as the mean Ϯ S.E.; *, p Ͻ 0.05 versus similarly treated Flox mice; #, p Ͻ 0.05 versus mice of the same genotype treated with the control ASO.
according to the manufacturers' instructions. Fast protein liquid chromatography was performed commercially (Wake Forest University).
Statistical Analysis-Differences between groups were assessed by a Student's t test. Bars and error bars correspond to the mean and S.E., respectively. Similar results were obtained in a second independent cohort.
Results
Insulin exerts its effects by binding and activating the insulin receptor, a tyrosine kinase that phosphorylates its targets, including insulin receptor substrate (IRS)1 and IRS2. This triggers a cascade of signaling events (reviewed in Ref. 26 ), ultimately suppressing glucose production and inducing lipogenesis in the liver.
To dissect the contribution of LXR to insulin-regulated gene expression, we utilized LIRKO mice. These mice show a Ͼ90% deletion of the insulin receptor in their livers (20) . Consequently, the hepatocytes of these mice are entirely unable to respond to insulin. Although the direct targets of the insulin receptor, IRS1 and IRS2, are unchanged or increased at the protein level, they are not phosphorylated and activated in response to insulin (20) . These mice are therefore hyperglycemic; they also show decreased lipogenesis and decreased plasma triglycerides (20, 22) .
We knocked down Lxr␣ in LIRKO mice using second generation ASO. These ASO reduced Lxr␣ 40 -90% in multiple tissues, including liver, white adipose tissue, kidney, spleen, and heart (data not shown), consistent with prior literature (27) .
Here, 4 -5-week-old female LIRKO mice and their littermate Flox controls were injected once per week with 50 mg/kg of oligonucleotide for five doses. Four days prior to the last dose, mice were switched to a high fructose diet to boost lipogenic gene expression (22, 28) .
The Lxr␣ ASO was effective in reducing hepatic Lxr␣ mRNA and protein levels by 60 -70% in mice of both genotypes (Fig. 1,  A and B) . Lxr␤ was slightly but significantly induced in Flox but not in LIRKO mice, whereas mRNA levels of retinoid X recep- tor (Rxr), which dimerizes with LXR, were not altered (Fig. 1A) . As expected, LIRKO livers showed undetectable amounts of insulin receptor, normal amounts of IRS1, and increased amounts of IRS2 (Fig. 1B) . As shown in Fig. 1C , neither knockout of the insulin receptor nor knockdown of Lxr␣ altered body weight.
In Flox mice, as expected, lipogenic gene expression was markedly reduced by knockdown of Lxr␣. Thus, Srebp-1c was decreased by 60%. Although total Chrebp was not significantly altered, the potent isoform, Chrebp-␤, was decreased by ϳ30% at the mRNA level. In parallel, the targets of these transcription factors, glucokinase (Gck), acetyl-CoA carboxylase (ACC), FASN, SCD1, and L-type pyruvate kinase (Pklr), were decreased 20 -70% at the mRNA and protein levels in Flox mice (Fig. 2, A and B) .
In LIRKO mice, Srebp-1c mRNA was decreased by 50% when compared with Flox mice, and although Chrebp-␤ trended lower in LIRKO mice, neither Chrebp-␤ nor total Chrebp was altered. In parallel, glucokinase mRNA was nearly absent in LIRKO livers, and Acc, Fasn, Scd1, and Pklr were decreased by 60 -90%. Intriguingly, knockdown of Lxr␣ had no further effect on lipogenic gene expression in LIRKO mice; moreover, FASN and SCD1 were almost undetectable by Western blot (Fig. 2, A and B) .
Consistent with these changes in gene expression, Lxr␣ knockdown decreased hepatic and plasma triglycerides in Flox mice without changing the lipolytic genes, hormone-sensitive lipase (Hsl) and adipose triglyceride lipase (Atgl), plasma FFA, or plasma lipoprotein lipase activity (Fig. 2, C-E) . When compared with Flox mice, LIRKO mice showed lower levels of hepatic triglycerides, a trend toward decreased plasma triglycerides, increased Atgl expression, and a decrease in plasma free fatty acids, despite a slight decrease in plasma lipoprotein lipase activity. These data suggest that in addition to decreased lipogenesis, increased fatty acid oxidation and decreased free fatty acid flux to the liver could contribute to the lower levels of hepatic triglycerides observed in LIRKO mice. No further changes in these parameters were noted with knockdown of Lxr␣.
In contrast to the lipogenic genes, the cholesterol efflux genes showed little response to Lxr␣ knockdown in Flox mice (Fig. 3A) , which is consistent with prior studies (29) . LIRKO mice showed increased levels of ATP-binding cassette, subfamily G, member 5 (Abcg5) and member 8 (Abcg8) when compared with Flox mice (Fig. 3A) , presumably due to increased action of Forkhead box protein O1 (FoxO1), which also drives these genes (30) . Knockdown of LXR␣ in LIRKO mice reduced Abcg5 in some but not all cohorts. Other LXR␣ targets, ATPbinding cassette subfamily G, member 1 (Abcg1), ATP-binding cassette, subfamily A, member 1 (Abca1), cholesterol 7␣-hydroxylase (Cyp7a1), and apolipoprotein E (ApoE), were unchanged by either the deletion of the hepatic insulin receptor or knockdown of Lxr␣.
Another important target of LXR is phospholipid transfer protein (Pltp) (31, 32) . PLTP participates in the remodeling of HDL particles, but has also been shown to be necessary for the secretion of apolipoprotein B (ApoB) and triglycerides (33) . LXR agonist treatment increases Pltp, and this promotes the formation of large, triglyceride-rich VLDL particles (34) . Although knockdown of Lxr␣ had little effect on Pltp in Flox mice, it increased Pltp expression and activity in LIRKO mice (Fig. 3, C and D) .
At the physiological level, Lxr␣ knockdown had little effect on hepatic cholesterol (Fig. 3B) , and produced subtle, although significant, changes in lipoprotein metabolism, particularly in LIRKO mice. Lxr␣ knockdown did not alter total cholesterol levels in the plasma of Flox mice but increased plasma levels of apolipoprotein B48 (Fig. 3, E and G) .
LIRKO mice showed relatively normal levels of plasma cholesterol, but an increase in plasma ApoB and a decrease in the proportion of HDL cholesterol (Fig. 3, E-G) , which is consistent with prior reports of LIRKO mice on the chow diet (21, 23) . Knockdown of Lxr␣ produced a slight but significant increase in plasma cholesterol that appeared to be due to increased HDL (Fig. 3, E and  F) . Plasma levels of apolipoprotein E (ApoE) and apolipoprotein A1 (ApoA1) were not altered in mice of either genotype (Fig. 3G) .
Recently, the enzyme Lpcat3 was identified as an LXR target (16) . Lpcat3 mRNA levels were similar in Flox and LIRKO mice and decreased 30% by Lxr␣ knockdown in both genotypes (Fig.  4A) . To further examine the effects of Lxr␣ knockdown on the phospholipid profile, a lipidomics analysis was performed. Knockdown of Lxr␣ increased slightly the amount of phosphatidylcholine in the livers of Flox mice (Fig. 5A ), but did not significantly alter the amounts of lysophosphatidylcholine or phosphatidylethanolamine (Fig. 5, B and C) .
In the phosphatidylcholine fraction, LIRKO mice showed a notable decrease in the 20:4-containing species, 16:0/20:4, 18:1/ 20:4, and 18:0/20:4 ( Table 1 ). Knockdown of Lxr␣ decreased hepatic 16:0/18:1 in mice of both genotypes but increased 18:0/ 20:4 in LIRKO mice. In the lysophosphatidylcholine fraction, LIRKO mice again showed a decrease in the proportion of 20:4; they also showed an increase in the proportion of 16:0, which was restored toward normal upon Lxr␣ knockdown ( Table 2 ). In the phosphatidylethanolamine fraction, the effects of hepatic insulin signaling and Lxr␣ knockdown were more subtle and variable (Table 3) .
Despite the fact that Lxr␣ knockdown did not produce a clear shift toward saturated fatty acids in the phosphatidylcholine fraction, it markedly increased expression of the inflammatory genes, monocyte chemotactic protein 1 (Mcp1) and tumor necrosis factor ␣ (Tnfa), in mice of both genotypes (Fig. 4B) . Lxr␣ knockdown also appeared to increase ER stress, as it increased activating transcription factor (Atf)3 in both Flox and LIRKO livers and increased ER-localized DnaJ homolog 4 (ERdj4) and produced a trend toward an increase in the spliced form of X-box-binding protein 1 (Xbp1) in LIRKO livers (Fig.  4C ). In parallel, there was no induction of ATF4 protein in either Flox or LIRKO livers, but a slight induction of phosphorylated PKR-like ER Kinase (PERK) in LIRKO livers upon knockdown of Lxr␣ (Fig. 4D ).
Discussion
LXR is a master regulator of lipogenesis, cholesterol metabolism, and inflammation. More recently, it has also been shown to play a role in determining the phospholipid profile of the cell and ER stress. Insulin activates LXR, which is necessary for the effects of insulin on lipogenesis. Our data show that in the absence of hepatic insulin signaling, Lxr␣ is dispensable for lipogenic gene expression; however, it is still required for the expression of Lpcat3 and the suppression of ER stress and inflammation.
These data underscore the importance of Lxr␣ in the regulation of the lipogenic genes by insulin. In particular, the fact that lipogenic gene expression was similar in mice with knockdown of Lxr␣ versus knock-out of the insulin receptor, as well as the fact that there was no additive effect of knockdown of Lxr␣ in the absence of the insulin receptor, indicates that at least under these conditions, the entire effect of insulin on lipogenic gene expression is dependent upon Lxr␣. This is somewhat surprising given that insulin induces SREBP-1c and the lipogenic genes through multi-
TABLE 1 The Effects of Lxr␣ knockdown on the PC composition of Flox and LIRKO livers
Flox and LIRKO mice were treated with the control or LXR ASO as described in the legend for Fig. 1 . The abundance of PC species was determined by LC/MS. Data are presented as the mean Ϯ S.E., n ϭ 5; *, p Ͻ 0.05 versus similarly treated Flox mice; #, p Ͻ 0.05 versus mice of the same genotype treated with the control ASO. Note that p16:0/18:1 and p16:0/18:0 indicate plasmalogens (ether rather than ester link at the sn-1 position). 
TABLE 2 The Effects of Lxr␣ knockdown on the LPC composition of Flox and LIRKO livers
Flox and LIRKO mice were treated with the control or LXR ASO as described in the legend for Fig. 1 
TABLE 3 The Effects of Lxr␣ knockdown on the PE composition of Flox and LIRKO livers
Flox and LIRKO mice were treated with the control or LXR ASO as described in the legend for (35); it also promotes the maturation and stability of the SREBP-1c protein (36 -38) .
The data also reveal a role for LXR␣ in the repression of Pltp in LIRKO livers. That is, LXR, in the absence of ligand, is known to recruit corepressors, such as nuclear receptor corepressor (NCoR) and silencing mediator of retinoic acid and thyroid hormone receptors (SMRT), which are released upon ligand binding (39) . The fact that Pltp expression is reduced in LIRKO mice, but normalized by knockdown of Lxr␣, indicates that insulin modifies the effects of LXR on the Pltp promoter, perhaps by altering its ability to recruit corepressors. These data also support the notion that LXR␣ plays an important role in suppressing ER stress as well as inflammation. The suppression of ER stress in these studies appeared to be at least partially independent of LPCAT3: Lpcat3 mRNA was decreased by knockdown of Lxr␣, but we did not detect sizeable and consistent decreases in the unsaturated fatty acid content of the phosphatidylcholine fraction. Thus, other links between LXR and ER stress likely exist.
Finally, these data indicate that the different arms of LXR␣ action become uncoupled in the absence of insulin. Thus, in LIRKO mice, the non-lipogenic targets of LXR are generally expressed in normal amounts. Furthermore, knockdown of Lxr␣ increases ER stress markers and inflammation in both LIRKO and Flox mice. Thus, in the absence of insulin, Lxr␣ retains activity toward the non-lipogenic genes. This suggests that insulin specifically activates the lipogenic arm of Lxr␣ activity, perhaps by activating some component of the transcriptional complex specifically associated with lipogenic genes (39) . In states of selective insulin resistance, such as Type 2 diabetes, insulin may continue to drive the lipogenic actions of LXR, promoting lipogenesis, fatty liver disease, and hypertriglyceridemia without inducing other arms of LXR action. This would explain how, in obesity and Type 2 diabetes, lipogenesis is increased even as ER stress (40) and inflammation are also increased (41) , and cholesterol efflux (42) is decreased.
In summary, our data show that insulin is specifically required for the lipogenic arm of LXR action. They further suggest that blocking the actions of insulin on LXR␣ may allow us to uncouple the beneficial effects of LXR agonists on reverse cholesterol transport and inflammation while preventing the development of steatosis and hypertriglyceridemia.
